Interomex BioPharmaceuticals

About:

Interomex develops and commercializes technologies for functional analysis of genes and proteins.

Website: https://www.interomex.com

Top Investors: Business Development Bank of Canada, Ventures West, GeneChem, T2C2 Capital

Description:

Interomex Biopharmaceuticals Inc. is dedicated to the identification of novel biological targets in key cellular processes with the aim of discovering lead compounds for the treatment of disease. The company’s proprietary Repressed Trans-activator (RTATM) technology can be used to detect protein-protein interactions between a host and an infectious agent, as well as within cells in normal and diseased states. A particular advantage of RTATM is its ability to detect the interactions of transcription transactivator proteins, which are key control points in viral infections and cell activation.